Table 1.
Group | ENaC activity, NPo | ENaC open probability, Po | Number of active ENaC, N |
---|---|---|---|
Control mice | 0.56 ± 0.12 | 0.19 ± 0.03 | 2.80 ± 0.44 |
ABCA1 KO mice | 2.33 ± 0.56* | 0.44 ± 0.06* | 5.00 ± 0.79* |
Control mice + Lovastatin | 0.24 ± 0.08& | 0.12 ± 0.04 | 2.00 ± 0.24 |
ABCA1 KO mice + Lovastatin | 0.38 ± 0.09 # | 0.16 ± 0.02 # | 2.40 ± 0.42 # |
Data presented are means ± SEM. Summary of total ENaC activity (NP O), the number of active ENaC, (N), and ENaC open probability (P O) in control mice and ABCA1 KO mice after 2 weeks of infusion with lovastatin.
P < .05, significantly different from control mice.
P < .05, significantly different from ABCA1 KO mice.
P < .05, significantly different from control mice.